Literature DB >> 9009157

Ornithine decarboxylase over-expression stimulates mitogen-activated protein kinase and anchorage-independent growth of human breast epithelial cells.

A Manni1, R Wechter, S Gilmour, M F Verderame, D Mauger, L M Demers.   

Abstract

In these experiments we tested the hypothesis that constitutive activation of polyamine(PA) biosynthesis may contribute to mammary carcinogenesis. Spontaneously immortalized normal human MCF-10A breast epithelial cells were infected with the retroviral vector pLOSN containing a cDNA which codes for a truncated and more stable ornithine decarboxylase (ODC), the rate-limiting enzyme in PA synthesis. Upon chronic selective pressure with alpha-difluoromethyl-ornithine (DFMO) (an irreversible inhibitor of ODC), infected MCF-10A cells exhibited an approximately 250-fold increase in ODC activity, which persisted despite discontinuation of DFMO. ODC-over-expressing MCF-10A cells showed a modest decrease in S-adenosylmethionine decarboxylase and an increase in spermidine/spermineN1-acetyltransferase. Analysis of cellular PA profile revealed a selective accumulation of putrescine without alterations in spermidine and spermine contents. Lesser degrees of increased ODC activity were obtained reproducibly by re-exposing the cells to incremental small doses of DFMO. We observed a bell-shaped dose-related positive effect of ODC activity on clonogenicity in soft agar of MCF-10A cells. Since anchorage-dependent growth was actually reduced, such positive influence on this feature of transformation was not a non-specific consequence of a growth advantage provided by ODC over-expression. In addition, we observed a close parallelism between the dose-dependent effects of ODC expression on clonogenicity and activity of the ERK-2 kinase, a central element of the MAPK cascade. Our data demonstrate an interaction between PA and the MAPK signalling pathway and suggest that the latter may be involved in ODC-induced transformation of mammary epithelial cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9009157     DOI: 10.1002/(sici)1097-0215(19970117)70:2<175::aid-ijc7>3.0.co;2-u

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  5 in total

1.  p44/42 mitogen-activated protein kinase is involved in the expression of ornithine decarboxylase in leukaemia L1210 cells.

Authors:  F Flamigni; A Facchini; C Capanni; C Stefanelli; B Tantini; C M Caldarera
Journal:  Biochem J       Date:  1999-07-15       Impact factor: 3.857

2.  Altered ornithine decarboxylase and S-adenosylmethionine decarboxylase expression and regulation in mouse fibroblasts transformed with oncogenes or constitutively active Mitogen-Activated Protein (MAP) kinase kinase.

Authors:  R A Hurta
Journal:  Mol Cell Biochem       Date:  2000-12       Impact factor: 3.396

3.  Increased expression of mitogen-activated protein kinase and its upstream regulating signal in human gastric cancer.

Authors:  Bin Liang; Shan Wang; Xue-Guang Zhu; Yong-Xiang Yu; Zhi-Rong Cui; You-Zhi Yu
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

4.  ODC (Ornithine Decarboxylase)-Dependent Putrescine Synthesis Maintains MerTK (MER Tyrosine-Protein Kinase) Expression to Drive Resolution.

Authors:  Arif Yurdagul; Na Kong; Brennan D Gerlach; Xiaobo Wang; Patrick Ampomah; George Kuriakose; Wei Tao; Jinjun Shi; Ira Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-01-06       Impact factor: 8.311

5.  Metastasis of hormone-independent breast cancer to lung and bone is decreased by alpha-difluoromethylornithine treatment.

Authors:  Monica M Richert; Pushkar A Phadke; Gail Matters; Douglas J DiGirolamo; Sharlene Washington; Laurence M Demers; Judith S Bond; Andrea Manni; Danny R Welch
Journal:  Breast Cancer Res       Date:  2005-08-09       Impact factor: 6.466

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.